Skip to main content
TipRanks
Go Ultimate75% OFF

Kaken Pharmaceutical Co (KKPCF) Ratios

4 Followers

Kaken Pharmaceutical Co Ratios

KKPCF's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, KKPCF's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio3.674.525.625.275.81
Quick Ratio3.043.604.724.535.02
Cash Ratio1.782.152.662.863.20
Solvency Ratio0.440.180.390.270.45
Operating Cash Flow Ratio0.98-0.530.140.440.70
Short-Term Operating Cash Flow Coverage7.74-2.880.672.403.46
Net Current Asset Value¥ 73.59B¥ 63.46B¥ 79.11B¥ 80.41B¥ 83.75B
Leverage Ratios
Debt-to-Assets Ratio0.020.020.020.020.02
Debt-to-Equity Ratio0.030.030.030.030.03
Debt-to-Capital Ratio0.020.030.030.030.03
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.251.211.191.221.20
Debt Service Coverage Ratio4.261.422.792.083.12
Interest Coverage Ratio751.29-19.98559.59470.471003.76
Debt to Market Cap0.020.020.030.030.03
Interest Debt Per Share101.62102.74102.47102.93101.82
Net Debt to EBITDA-2.28-7.19-3.72-5.93-3.49
Profitability Margins
Gross Profit Margin61.96%51.05%53.49%54.20%54.68%
EBIT Margin20.70%3.07%13.62%9.36%18.29%
EBITDA Margin23.42%7.39%17.45%12.88%21.55%
Operating Profit Margin22.37%-1.17%13.20%10.96%22.44%
Pretax Profit Margin20.67%3.01%13.60%9.34%18.26%
Net Profit Margin14.83%2.79%11.14%7.45%12.56%
Continuous Operations Profit Margin14.83%2.79%11.14%7.45%12.56%
Net Income Per EBT71.75%92.69%81.92%79.80%68.77%
EBT Per EBIT92.39%-257.29%102.97%85.23%81.37%
Return on Assets (ROA)7.32%1.20%4.68%3.27%5.78%
Return on Equity (ROE)9.14%1.45%5.58%3.99%6.93%
Return on Capital Employed (ROCE)13.14%-0.57%6.23%5.50%11.68%
Return on Invested Capital (ROIC)9.21%-0.52%4.98%4.27%7.82%
Return on Tangible Assets8.15%1.39%4.89%3.41%6.08%
Earnings Yield8.15%1.37%6.13%3.92%6.46%
Efficiency Ratios
Receivables Turnover4.443.383.033.793.75
Payables Turnover4.304.974.725.455.80
Inventory Turnover1.881.971.952.152.30
Fixed Asset Turnover3.402.832.842.862.95
Asset Turnover0.490.430.420.440.46
Working Capital Turnover Ratio1.111.000.810.810.83
Cash Conversion Cycle191.36220.03229.98199.36193.03
Days of Sales Outstanding82.20108.01120.3096.3697.26
Days of Inventory Outstanding194.07185.40187.02169.93158.68
Days of Payables Outstanding84.9173.3977.3466.9362.91
Operating Cycle276.27293.42307.31266.29255.94
Cash Flow Ratios
Operating Cash Flow Per Share780.36-292.2368.29246.28351.15
Free Cash Flow Per Share671.92-371.2610.86187.56265.39
Dividend Paid and CapEx Coverage Ratio2.63-1.170.331.181.49
Capital Expenditure Coverage Ratio7.20-3.701.194.194.09
Operating Cash Flow Coverage Ratio7.74-2.880.672.403.46
Operating Cash Flow to Sales Ratio0.32-0.140.040.130.18
Free Cash Flow Yield14.99%-8.97%0.31%5.08%6.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio12.2673.2116.3025.5215.47
Price-to-Sales (P/S) Ratio1.822.041.821.901.94
Price-to-Book (P/B) Ratio1.121.060.911.021.07
Price-to-Free Cash Flow (P/FCF) Ratio6.67-11.15319.1119.7014.66
Price-to-Operating Cash Flow Ratio5.74-14.1750.7715.0011.08
Price-to-Earnings Growth (PEG) Ratio0.17-0.870.35-0.60-0.56
Enterprise Value Multiple5.4820.436.698.845.53
Enterprise Value120.76B116.09B84.06B83.11B90.56B
EV to EBITDA5.4820.436.698.845.53
EV to Sales1.281.511.171.141.19
EV to Free Cash Flow4.71-8.25205.0211.798.98
EV to Operating Cash Flow4.06-10.4832.628.986.79
Tangible Book Value Per Share3494.263253.123611.653462.623425.33
Shareholders’ Equity Per Share3999.633893.773809.393626.653626.97
Tax and Other Ratios
Effective Tax Rate0.280.070.180.200.31
Revenue Per Share2464.102027.641909.111942.562002.05
Net Income Per Share365.4256.55212.66144.79251.44
Tax Burden0.720.930.820.800.69
Interest Burden1.000.981.001.001.00
Research & Development to Revenue0.200.270.170.220.11
SG&A to Revenue0.200.250.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality2.14-5.170.321.360.96

Currency in JPY